Kenneth C. Frazier

2017

In 2017, Kenneth C. Frazier earned a total compensation of $17.6M as Chairman, President and Chief Executive Officer at Merck & Co., a 19% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$504,658
Non-Equity Incentive Plan$2,686,575
Option Awards$3,750,000
Salary$1,572,212
Stock Awards$8,814,767
Other$314,875
Total$17,643,087

Frazier received $8.8M in stock awards, accounting for 49.96% of the total pay in 2017.

Frazier also received $504.7K of change in pension value and nonqualified deferred compensation earnings, $2.7M in non-equity incentive plan, $3.8M in option awards, $1.6M in salary and $314.9K in other compensation.

Rankings

In 2017, Kenneth C. Frazier's compensation ranked 199th out of 14,643 executives tracked by ExecPay. In other words, Frazier earned more than 98.6% of executives.

ClassificationRankingPercentile
All
199
out of 14,643
99th
Division
Manufacturing
53
out of 5,750
99th
Major group
Chemicals And Allied Products
14
out of 2,038
99th
Industry group
Drugs
11
out of 1,689
99th
Industry
Pharmaceutical Preparations
10
out of 1,307
99th
Source: SEC filing on April 9, 2018.

Frazier's colleagues

We found four more compensation records of executives who worked with Kenneth C. Frazier at Merck & Co. in 2017.

2017

Adam Schechter

Merck & Co.

Executive Vice President and President, Global Human Health

2017

Roger Perlmutter

Merck & Co.

Executive Vice President and President, Merck Research Laboratories

2017

Robert Davis

Merck & Co.

Chief Financial Officer

2017

Michael Holston

Merck & Co.

General Counsel

News

You may also like